Exchange: NASDAQ·Updated 07:59 PM EDT
ISRG logo

ISRGIntuitive Surgical Inc

$406.78
$4.60
(1.14%)
Today
Closed $406.78
$1.04
(0.26%)
After Hours
EarningsJul 16
Mkt Cap$144.07B
Vol4.4M
36

Bearish Sentiment

How do you feel about ISRG?

News
all
press releases
10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics
TXG collaborates with the Cleveland Clinic to advance bladder cancer diagnostics using Flex Apex, Xenium and potentially Atera.
Zacks
News Placeholder
More News
News Placeholder
Cencora Launches Enhanced Nucleus Solution for Specialty Practices
COR's enhanced Nucleus platform targets complex specialty medication workflows, with a pilot underway across more than 20 physician practice sites.
Zacks
News Placeholder
Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns
Rising P/E ratios can signal confidence and momentum. Discover 5 stocks backed by strong earnings growth and upside potential.
Zacks
News Placeholder
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.
Zacks
News Placeholder
Billionaire Ken Griffin Sold Amazon and Nvidia but Quietly Loaded Up on This Healthcare Giant
Key PointsCitadel Advisors bought the dip in Intuitive Surgical, a leading medical device company...
Nasdaq News: Markets
News Placeholder
InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR
NSPR's positive CGUARDIANS II data show 100% acute device success, supporting a potential FDA approval for CGuard Prime TCAR in late 2026.
Zacks
News Placeholder
Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $416.55, marking a +1.34% move from the previous day.
Zacks
News Placeholder
Are Options Traders Betting on a Big Move in Intuitive Surgical Stock?
Investors need to pay close attention to (Ticker) stock based on the movements in the options market lately.
Zacks
News Placeholder
QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use
QGEN's QIAcuity expansion adds gene expression assays, multiplexing, automation and analysis tools to drive dPCR adoption.
Zacks
News Placeholder
ISRG's Capital Placement Surge: Demand Strength or Upgrade Cycle Peak?
ISRG placed 431 da Vinci systems in Q1 2026, but rising trade-ins and leasing growth raise questions about whether demand is structural or upgrade-driven.
Zacks
<
1
2
...
>

Advertisement|Remove ads.